60 Degrees Pharmaceuticals
SXTP
7 hedge funds and large institutions have $62.9K invested in 60 Degrees Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 0 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
74% more capital invested
Capital invested by funds: $36.1K → $62.9K (+$26.8K)
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more ownership
Funds ownership: 0.26% → 0.26% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DS
DRW Securities
Chicago,
Illinois
|
+$38.4K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.22K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$823 |
| 4 |
Citigroup
New York
|
+$286 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$104 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DS
1
DRW Securities
Chicago,
Illinois
| $37.3K | +$38.4K | +6,303 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $18.3K | -$104 | -17 | -0.5% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $4.65K | +$823 | +135 | +21% |
|
|
4
UBS Group
Zurich,
Switzerland
| $2.18K | +$2.22K | +365 | +9,125% |
|
|
5
Citigroup
New York
| $278 | +$286 | +47 | New |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $141 | – | – | – |
|
|
7
Bank of America
Charlotte,
North Carolina
| $44 | +$30 | +5 | +167% |
|
SXTP Hedge Fund Activity: Q3 2025 in Review
7 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in 60 Degrees Pharmaceuticals (SXTP) for Q3 2025, worth a combined $62.9K — up 74% from $36.1K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new SXTP positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was DRW Securities, opening a new position worth an estimated $38.4K. The largest seller was Geode Capital Management, cutting an estimated $104.
- 7 institutional investors held 60 Degrees Pharmaceuticals (SXTP) as of Q3 2025, up from 5 in Q2 2025.
- Funds reported $62.9K of 60 Degrees Pharmaceuticals stock for Q3 2025, up 74% quarter-over-quarter.
- 2 funds opened new 60 Degrees Pharmaceuticals positions in Q3 2025 and 0 closed out, a net change of +2 holders.
- The largest 60 Degrees Pharmaceuticals buyer in Q3 2025 was DRW Securities, an estimated $38.4K added.
- The largest 60 Degrees Pharmaceuticals seller in Q3 2025 was Geode Capital Management, an estimated $104 sold.
Based on aggregated 13F filings for Q3 2025.